https://orcid.org/0000-0001-9406-0941
References
- American Cancer Society. Cancer facts & figures. New York (NY): American Cancer Society; 2017.
- DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643–8653.
- Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Targeting. 2015;24(3):1–13.
- Peng X, Rahman MA, Mao H, et al. Nanomaterials facilitate tumor targeting and drug delivery. Austin J Cancer & Clinical Res. 2016;3(2):1072.
- Zhang T, Cui H, Fang CY, et al. Targeted nanodiamonds as phenotype specific photoacoustic contrast agents for breast cancer. Nanomedicine. 2015;10(4):573–587.
- Ho D. Nanodiamonds: applications in biology and nanoscale medicine. Brussel (Belgium): Springer; 2009.
- Poklepovic A, Qu Y, Dickinson M, et al. Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardio-Oncology. 2018;4(1):7.
- Chen T, Shen HM, Deng ZY, et al. A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis. Mol Med Rep. 2017;15(4):2057–2066.
- Chatterjee K, Zhang J, Honbo N, et al. Doxorubicin cardiomyopathy. Cardiology. 2010;115(2):155–162.
- Kato Y, Ozawa S, Miyamoto C, et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 2013;13(1):89.
- Som A, Bloch S, Ippolito JE, et al. Acidic extracellular pH of tumors induces octamer-binding transcription factor 4 expression in murine fibroblasts in vitro and in vivo. Sci Rep. 2016;6(1):27803.
- Li Y, Zhou X, Wang D, et al. Nanodiamond mediated delivery of chemotherapeutic drugs. J Mater Chem. 2011;21(41):16406–16412.
- Salaam AD, Hwang P, McIntosh R, et al. Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer. Beilstein J Nanotechnol. 2014;5:937–945.
- Man HB, Ho D. Nanodiamonds as platforms for biology and medicine. J Lab Autom. 2013;18(1):12–18.
- Shimkuna RA, Robinson E, Lam R, et al. Nanodiamond–insulin complexes as pH-dependent protein delivery vehicles. Biomaterials. 2009;30:5720–5728.
- Zhou Y, Kumon RE, Cui J, et al. The size of sonoporation pores on the cell membrane. Ultrasound Med Biol. 2009;35(10):1756–1760.
- Liu Y, Wang W, Yang J, et al. pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J Pharma Sci. 2013;8(3):159–167.
- Marunaka Y. Roles of interstitial fluid pH in diabetes mellitus: glycolysis and mitochondrial function. World J Diabetes. 2015;6(1):125–135.
- Naim B, Brumfeld V, Kapon R, et al. Passive and facilitated transport in nuclear pore complexes is largely uncoupled. J Biol Chem. 2007;282(6):3881–3888.